• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强型渗透和保留效应(EPR)的应用:基于纳米颗粒的精准工具,用于靶向治疗和诊断剂在癌症中的应用。

Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer.

机构信息

National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad, An Institute of National Importance, Government of India, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Palaj, Opposite Air Force Station, Gandhinagar, Gujarat 382355, India.

National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad, An Institute of National Importance, Government of India, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Palaj, Opposite Air Force Station, Gandhinagar, Gujarat 382355, India.

出版信息

Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276. doi: 10.1016/j.msec.2019.01.066. Epub 2019 Jan 18.

DOI:10.1016/j.msec.2019.01.066
PMID:30813007
Abstract

In tumorous tissues, the absence of vasculature supportive tissues intimates the formation of leaky vessels and pores (100 nm to 2 μm in diameter) and the poor lymphatic system offers great opportunity to treat cancer and the phenomenon is known as Enhanced permeability and retention (EPR) effect. The trends in treating cancer by making use of EPR effect is increasing day by day and generate multitudes of possibility to design novel anticancer therapeutics. This review aimed to present various factors affecting the EPR effect along with important things to know about EPR effect such as tumor perfusion, lymphatic function, interstitial penetration, vascular permeability, nanoparticle retention etc. This manuscript expounds the current advances and cross-talks the developments made in the of EPR effect-based therapeutics in cancer therapy along with a transactional view of its current clinical and industrial aspects.

摘要

在肿瘤组织中,缺乏支持性的脉管组织提示形成渗漏性血管和孔隙(直径 100nm 至 2μm),而不良的淋巴系统为治疗癌症提供了很好的机会,这种现象被称为增强的通透性和保留(EPR)效应。利用 EPR 效应治疗癌症的趋势日益增加,为设计新型抗癌治疗方法提供了无数可能性。本综述旨在介绍影响 EPR 效应的各种因素,以及关于 EPR 效应的一些重要知识,如肿瘤灌注、淋巴功能、间质渗透、血管通透性、纳米颗粒保留等。本文阐述了当前的进展,并交流了基于 EPR 效应的治疗在癌症治疗中的发展,以及其当前临床和工业方面的转化观点。

相似文献

1
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer.增强型渗透和保留效应(EPR)的应用:基于纳米颗粒的精准工具,用于靶向治疗和诊断剂在癌症中的应用。
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276. doi: 10.1016/j.msec.2019.01.066. Epub 2019 Jan 18.
2
Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.大分子药物在实体瘤中的高通透性和滞留效应:靶向抗癌纳米药物的一扇大门
J Drug Target. 2007 Aug-Sep;15(7-8):457-64. doi: 10.1080/10611860701539584.
3
Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.载有紫杉醇的胶束可增强纳米药物在肿瘤中的跨血管通透性和滞留性。
Int J Pharm. 2015 Feb 20;479(2):399-407. doi: 10.1016/j.ijpharm.2015.01.009. Epub 2015 Jan 8.
4
The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.有机纳米材料在癌症治疗中的临床转化:聚焦于聚合物纳米粒子、胶束、脂质体和外泌体。
Curr Med Chem. 2018;25(34):4224-4268. doi: 10.2174/0929867324666170830113755.
5
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.载各种抗癌药物的 PLGA 纳米粒通过 EPR 效应的肿瘤递药。
Adv Drug Deliv Rev. 2011 Mar 18;63(3):170-83. doi: 10.1016/j.addr.2010.10.008. Epub 2010 Oct 20.
6
S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.S-亚硝基化人血清白蛋白二聚体作为新型纳米 EPR 增强剂,可应用于大分子抗肿瘤药物,如胶束和脂质体。
J Control Release. 2015 Nov 10;217:1-9. doi: 10.1016/j.jconrel.2015.08.036. Epub 2015 Aug 22.
7
Targeting endothelial permeability in the EPR effect.针对 EPR 效应中的血管内皮通透性。
J Control Release. 2023 Sep;361:212-235. doi: 10.1016/j.jconrel.2023.07.039. Epub 2023 Aug 8.
8
Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate' for nanomedicine in preclinical studies?人体实体瘤与增强渗透和滞留效应的临床相关性:纳米医学在临床前研究中的“黄金之门”?
Nanomedicine (Lond). 2023 Jan;18(2):169-190. doi: 10.2217/nnm-2022-0257. Epub 2023 Apr 12.
9
Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.“EPR”效应的因素与机制以及包括丝裂霉素肝动脉栓塞化疗药物(SMANCS)在内的大分子药物的增强抗肿瘤作用
Adv Exp Med Biol. 2003;519:29-49. doi: 10.1007/0-306-47932-X_2.
10
Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles.增强型通透性和保留效应:纳米颗粒实现实体瘤靶向的关键促进因素。
Photodiagnosis Photodyn Ther. 2022 Sep;39:102915. doi: 10.1016/j.pdpdt.2022.102915. Epub 2022 May 18.

引用本文的文献

1
A multimodal approach to assess a liposomal carrier's biodistribution, stability, and clearance.一种评估脂质体载体生物分布、稳定性和清除率的多模态方法。
Photoacoustics. 2025 Aug 22;46:100763. doi: 10.1016/j.pacs.2025.100763. eCollection 2025 Dec.
2
Nanoparticles for Cancer Immunotherapy: Innovations and Challenges.用于癌症免疫治疗的纳米颗粒:创新与挑战
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1086. doi: 10.3390/ph18081086.
3
Liposome-Loaded Mesenchymal Stem Cells Enhance Tumor Accumulation and Anti-Tumor Efficacy of Doxorubicin in Mouse Tumor Models of Melanoma.
脂质体负载的间充质干细胞增强阿霉素在小鼠黑色素瘤肿瘤模型中的肿瘤蓄积及抗肿瘤疗效。
Pharmaceutics. 2025 Jul 22;17(8):947. doi: 10.3390/pharmaceutics17080947.
4
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.异鼠李素:抗癌机制及纳米制剂驱动递送的最新进展综述
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
5
Beyond borders: engineering organ-targeted immunotherapies to overcome site-specific barriers in cancer.超越国界:设计靶向器官的免疫疗法以克服癌症中的位点特异性障碍
Drug Deliv Transl Res. 2025 Aug 11. doi: 10.1007/s13346-025-01935-4.
6
Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review.癌症相关成纤维细胞在癌症耐药性和癌症进展中的作用:综述
Cell Death Discov. 2025 Jul 24;11(1):341. doi: 10.1038/s41420-025-02566-x.
7
Nanocarrier drug delivery systems for gynecological cancer therapeutics.用于妇科癌症治疗的纳米载体药物递送系统。
J Control Release. 2025 Sep 10;385:114028. doi: 10.1016/j.jconrel.2025.114028. Epub 2025 Jul 17.
8
PLGA-based herb Toosendanin delivery system for efficient therapy of oral squamous cell carcinoma.基于聚乳酸-羟基乙酸共聚物的川楝素递送系统用于口腔鳞状细胞癌的高效治疗
BMC Complement Med Ther. 2025 Jul 2;25(1):217. doi: 10.1186/s12906-025-04957-0.
9
Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside.癌症治疗中的纳米医学:从实验室到临床的当前视角
Mol Cancer. 2025 Jun 9;24(1):169. doi: 10.1186/s12943-025-02368-w.
10
Polymer Nanoparticles Advancements for Gynecological Cancers.用于妇科癌症的聚合物纳米颗粒进展
Int J Nanomedicine. 2025 May 26;20:6721-6742. doi: 10.2147/IJN.S527023. eCollection 2025.